Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 661 (LINC00661) is a human gene encoding a long non-coding RNA—a type of RNA molecule that does not code for a protein but may play roles in regulating the expression of other genes. LINC00661 belongs to the lncRNA class and is found in the human genome as catalogued by major genomics resources[1][3][7][8]. While detailed functional studies specifically about LINC00661 are limited, lncRNAs as a class are increasingly recognized for their diverse roles in gene regulation, chromatin remodeling, and potential involvement in cancer biology. Some lincRNAs show altered expression in cancer and may regulate cancer-relevant pathways, but LINC00661 itself is not currently considered a direct therapeutic target, nor are there drugs available that target it directly or are approved for its modulation[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 661 (LINC00661).